Cladribine is a purine nucleoside analogue that accumulates in lymphocytes and selectively depletes B and T cells, used for hairy cell leukaemia and, in oral pulse-dosing form, for relapsing multiple sclerosis. Simson Pharma's Cladribine reference standard and impurities support the stringent stability-indicating testing this lymphocyte-depleting agent requires.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cladribine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.